Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04749043 · ClinicalTrials.gov registry record · NA

Virtual Reality Compared to Nitrous Oxide for Labor Analgesia

A NA study of Labor Pain, sponsored by Brendan Carvalho.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04749043: Completed NA study of Labor Pain, sponsored by Brendan Carvalho.

NCT04749043 is a NA study of Labor Pain that has completed, run by Brendan Carvalho. The registered enrollment target is 20 participants, below the 202-participant average among 14 other Labor Pain trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04749043, a NA study of Labor Pain, has completed, sponsored by Brendan Carvalho.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headsets) are non-inferior to conventional therapy (nitrous oxide) for addressing maternal needs during labor who desire non-epidural pain relief.

Primary Outcome

Patient satisfaction with pain relief on a scale of 0-10

Conditions Studied

Interventions

  • DRUG Nitrous oxide
  • DEVICE Oculus Quest 2 Virtual Reality Device

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-02-18
Est. Completion 2023-12-31
Phase NA
Brendan Carvalho

2 total trials

What the finished NCT04749043 record still lists

NCT04749043 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 202-participant average among 14 other Labor Pain trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Labor Pain appearing as the primary indexed condition, and to 2 interventions - of which Nitrous oxide is the first listed.

NCT04749043 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04749043 about?

NCT04749043 is a clinical study titled "Virtual Reality Compared to Nitrous Oxide for Labor Analgesia". The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headsets) are non-inferior to conventional therapy (nitrous oxide) for addressing maternal needs during labor who desire non-epidural pain relief.

What is the current status of trial NCT04749043?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-02-18. Estimated completion is 2023-12-31.

What conditions does trial NCT04749043 study?

This clinical trial studies the following conditions: Labor Pain.

What interventions are being tested in trial NCT04749043?

The interventions under investigation include: Nitrous oxide (DRUG), Oculus Quest 2 Virtual Reality Device (DEVICE).

Who is sponsoring clinical trial NCT04749043?

This trial is sponsored by Brendan Carvalho, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04749043 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Labor Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04749043's enrollment target sits among peer trials

20 14th of 14 higher than 1 of 14 other Labor Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Labor Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04749043, the US trial registry maintained by the National Library of Medicine. NCT04749043 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.